A FibroScan is not the same as a standard ultrasound, though the two tests share some similarities. Both use sound waves and a handheld probe placed on your skin, but they measure fundamentally different things. A conventional ultrasound creates a picture of your liver’s shape and structure, while a FibroScan measures how stiff your liver tissue is, which reveals scarring and fatty changes that a regular ultrasound can miss entirely.
How Each Test Works
A standard abdominal ultrasound sends high-frequency sound waves into your body. Those waves bounce off organs and tissues at different speeds depending on their density, and a computer assembles the reflections into a real-time image. Your doctor can see the liver’s size, shape, and blood flow, and spot things like cysts, tumors, or gallstones. What a standard ultrasound can’t do well is detect early-stage scarring (fibrosis) or measure how much fat has built up in liver cells.
A FibroScan, formally called transient elastography, takes a different approach. The probe sends painless, low-frequency vibrations into your liver. These vibrations create what are called shear waves that travel through the tissue and bounce back. The speed at which those waves return tells the machine how stiff or elastic the tissue is. Stiffer tissue means more scarring. The device also captures a second measurement called CAP, which estimates the percentage of liver cells containing fat. So in a single session, a FibroScan gives two distinct readings that a regular ultrasound simply isn’t designed to provide.
What Each Test Can Detect
Standard ultrasound excels at structural problems. It can identify liver tumors, fluid collections, bile duct blockages, and changes in liver size. It’s often the first imaging test ordered when a doctor suspects liver disease because it provides a broad overview of what’s happening anatomically. However, it has poor sensitivity for fibrosis. By the time scarring shows up clearly on a conventional ultrasound, liver disease is usually advanced.
FibroScan fills that gap. A large multicenter study of patients with chronic viral hepatitis found that FibroScan had high overall accuracy for detecting cirrhosis, the most severe stage of scarring, with an AUROC (a measure of diagnostic accuracy) of 0.89 to 0.90. That outperformed blood-based biomarker tests, which scored between 0.77 and 0.86 for cirrhosis detection. For earlier, intermediate stages of fibrosis, accuracy was more moderate across all noninvasive methods, and a liver biopsy may still be needed to confirm those middle stages.
The American Association for the Study of Liver Diseases (AASLD) recommends imaging-based tools like FibroScan for identifying fatty liver disease specifically, noting that blood tests alone aren’t accurate enough for that purpose. FibroScan is also recommended as a confirmatory step when blood tests suggest possible advanced fibrosis.
Understanding FibroScan Results
A FibroScan gives you two numbers. The first is liver stiffness, measured in kilopascals (kPa). Normal results fall between 2 and 7 kPa. About 90 to 95 percent of healthy people without liver disease score below 7.0 kPa, with a median around 5.3 kPa. Scores above 7 kPa suggest a roughly 85 percent probability of at least significant fibrosis. The threshold for cirrhosis is around 14 kPa. A person with chronic hepatitis C and a stiffness reading above 14 kPa has approximately a 90 percent chance of having cirrhosis. The highest possible reading is 75 kPa.
The second number is your CAP score, measured in decibels per meter (dB/m), which estimates fatty change. A score below 238 dB/m is considered normal (up to 5 percent fat in liver cells). Scores between 238 and 260 dB/m indicate mild fat buildup, covering roughly 11 to 33 percent of liver cells. Between 260 and 290 dB/m reflects moderate fatty change (34 to 66 percent), and anything above 290 dB/m signals that more than two-thirds of liver cells contain fat.
A standard ultrasound doesn’t produce either of these measurements. It may note that the liver looks “bright” or “echogenic,” which can suggest fat, but it can’t quantify how much fat is present or assign a fibrosis stage.
What to Expect During Each Procedure
Both tests are painless and require no sedation, but they differ in a few practical ways. A standard abdominal ultrasound typically requires you to fast for 8 to 12 hours beforehand so that the gallbladder is fully distended and the images are clear. A technician applies gel to your abdomen and moves a transducer across your skin for about 20 to 30 minutes while capturing images from multiple angles.
For a FibroScan, you’ll lie on your back with your right arm raised behind your head to expose your rib area. The technician places the probe on your right side over the liver and triggers a series of pulses. Each pulse feels like a gentle flick against your skin. The scan itself usually takes less than 15 minutes, though the full appointment, including preparation, may last up to an hour. You won’t need anyone to drive you home, and there’s no recovery time. Wearing loose-fitting clothing makes the process easier since your abdominal area needs to be exposed.
When Doctors Order One Over the Other
These tests aren’t interchangeable, and in many cases your doctor will order both at different points in your care. A standard ultrasound is typically the starting point for evaluating liver symptoms, screening for liver cancer in high-risk patients, or investigating abnormal blood work. It answers the question: does the liver look structurally normal?
A FibroScan is ordered when the concern is specifically about fibrosis or fat accumulation. Common reasons include monitoring chronic hepatitis B or C, evaluating suspected fatty liver disease, tracking fibrosis progression over time, or checking liver health in people with heavy alcohol use. Because FibroScan quantifies stiffness and fat with specific numbers, it’s also useful for tracking changes between visits in a way that standard ultrasound can’t match.
Some patients need both: an ultrasound to check for masses or structural abnormalities, and a FibroScan to measure scarring and fat. Neither test replaces the other, and neither fully replaces a liver biopsy for cases where the diagnosis remains uncertain after noninvasive testing.